No evidence exists of risk from vaccinating pregnant women with bacterial vaccines or toxoids. However, animal reproduction studies have not been conducted with Tetavax.
It is not known whether Tetavax can cause fetal harm when administered to a pregnant women or can affect reproduction capacity. Tetavax should be given to a pregnant women only if clearly needed.
It is not known whether Tetavax is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Tetavax is administered to a nursing woman. Considering the experimental and clinical data currently available, the vaccine may be prescribed at any stage of pregnancy.